Health-related quality of life for immediate versus delayed androgen-deprivation therapy in patients with asymptomatic, non-curable prostate cancer (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial-Reference-Cited by-同舟云学术

Health-related quality of life for immediate versus delayed androgen-deprivation therapy in patients with asymptomatic, non-curable prostate cancer (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial

Published:2017-09 Issue:9 Volume:18 Page:1192-1201
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Duchesne Gillian M,Woo Henry H,King Madeleine,Bowe Steven J,Stockler Martin R,Ames Alice,D'Este Catherine,Frydenberg Mark,Loblaw Andrew,Malone Shawn,Millar Jeremy,Tai Keen Hun,Turner Sandra

Publisher

Elsevier BV

Subject

Oncology

Reference24 articles.

1. Natural history of progression after PSA elevation following radical prostatectomy;Pound;JAMA,1999

2. The natural history and predictors of outcome following biochemical relapse in the dose escalation era for prostate cancer patients undergoing definitive external beam radiotherapy;Zumsteg;Eur Urol,2015

3. Prognostic factors for prostate cancer endpoints following biochemical failure: a review of the literature;Nguyen;Cureus,2015

4. Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial;Denham;Lancet Oncol,2012

5. The implications of ageing and life expectancy in prostate cancer treatment;Kalra;Nat Rev Urol,2016

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Updates to Advanced Prostate Cancer: AUA/SUO Guideline (2023);Journal of Urology;2023-06

3. Intermittent Hormonal Therapy in Biochemical Recurrence of Prostate Cancer Is Worth Considering Because of Mitigation of Cardiovascular Events and Reduction of Other Effects;European Urology Focus;2023-05

4. Androgen-deprivation therapy with leuprolide increases abdominal adiposity without causing cardiac dysfunction in middle-aged male mice: effect of sildenafil;American Journal of Physiology-Regulatory, Integrative and Comparative Physiology;2023-04-01

5. Differences in Quality of Life between German and Dutch Patients with Prostate Cancer Treated with Robot-assisted Radical Prostatectomy: Implications for International Multicenter Randomized Controlled Trials;European Urology Focus;2023-02